TGTGInsighttelegram intelligenceLIVE / telegram public index
← Python Заметки

TGINSIGHT SIMILAR POSTS

Најди сличен содржај

Изворен канал @pythonotes · Post #76 · 27 апр.

Ранее я делал серию постов про битовые операторы. Вот вам ещё один наглядный пример как это используется в Python в модуле re. Чтобы указать флаг для компилятора нам надо указать его после передаваемой строки. Например, добавляем флаг для игнорирования переноса строки. pattern = re.compile(r"(\w+)+") words = pattern.search(text, re.DOTALL) А как указать несколько флагов? Ведь явно будут ситуации когда нам потребуется больше одного. Кто читал посты по битовые операторы уже понял как. pattern.search(text, re.DOTALL | re.VERBOSE) А теперь смотрим исходники, что находится в этих атрибутах? Не удивительно, степени двойки. Почему? Потому что каждое следующее значение это сдвиг единицы влево. >>> for n in [1, 2, 4, 8, 16, 32, 64, 128, 256]: >>> print(bin(n)) 0b1 0b10 0b100 0b1000 0b10000 0b100000 0b1000000 0b10000000 0b100000000 Чтобы было понятней, давайте напишем тоже самое но иначе, добавим ведущие нули: 000000001 000000010 000000100 000001000 000010000 000100000 001000000 010000000 100000000 Не понятно что тут происходит? Читай три поста про битовые операторы начиная с этого ➡️https://t.me/pythonotes/45 В общем, это пример применения побитовых операций в самом Python. Теперь вы знаете Python еще немного лучше) #tricks#regex#libs

Резултати

Пронајдени 5 слични објави

Пребарај: #medicalresearch

当前筛选 #medicalresearch清除筛选
BadVolf

@badvolfnews · Post #2073 · 17.02.2025 г., 13:37

🚨 Just had an intriguing discovery at the Blokhin Institute in Moscow, Russia. While waiting for my doctor's appointment, I decided to explore the institute's museum. Among the exhibits, I stumbled upon a personal letter and invitation from Edward Kennedy to one of the institute's doctors. This was during the Cold War era, which makes this find even more fascinating. It seems that even amidst political tensions, there was recognition of the significant contributions Russia has made to arts and sciences. This glimpse into history reminds us of the importance of collaboration in fields like medicine, where advancements benefit everyone, regardless of borders. #BlokhinInstitute#ColdWarHistory#MedicalResearch#InternationalCollaboration#RussianAchievements

Venture Village Wall 🦄

@venturevillagewall · Post #3574 · 20.12.2024 г., 09:33

Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch

Venture Village Wall 🦄

@venturevillagewall · Post #3582 · 20.12.2024 г., 09:34

$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 21.12.2024 г., 10:23

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 18.12.2024 г., 12:11

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform